Sutent and Subdural haematoma - a phase IV clinical study of FDA data

Summary:

Subdural haematoma is reported as a side effect among people who take Sutent (sunitinib malate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Coumadin, and have Deep venous thrombosis.

The phase IV clinical study analyzes which people have Subdural haematoma when taking Sutent. It is created by eHealthMe based on reports of 44,359 people who have side effects when taking Sutent from the FDA, and is updated regularly.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

What is Subdural haematoma?

Subdural haematoma (blood collects between the skull and the surface of the brain) is found to be associated with 998 drugs and 1,084 conditions by eHealthMe. Check the latest studies of Subdural haematoma.

On Aug, 04, 2026

44,359 people reported to have side effects when taking Sutent.
Among them, 21 people (0.05%) have Subdural haematoma.

Among these 21 people:

How long have people been on Sutent when they have Subdural haematoma? *

What is the gender of people who have Subdural haematoma when taking Sutent? *

female: 36.84 %
male: 63.16 %

What is the age of people who have Subdural haematoma when taking Sutent? *

What are other drugs people take besides Sutent? *

What are other side effects people have besides Subdural haematoma? *

Fall: 4 people, 19.05%
Thrombocytopenia (decrease of platelets in blood): 3 people, 14.29%
Sinusitis (inflammation of sinus): 3 people, 14.29%
Intraventricular Haemorrhage (intraventricular bleeding): 3 people, 14.29%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 3 people, 14.29%
Bone Marrow Failure: 2 people, 9.52%
Headache (pain in head): 2 people, 9.52%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 9.52%
Abdominal Pain: 2 people, 9.52%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 9.52%

What are the existing conditions these people have? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 7 people, 33.33%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 6 people, 28.57%
High Blood Pressure: 4 people, 19.05%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 14.29%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 14.29%
Gastrointestinal Stromal Tumor: 2 people, 9.52%
Vaginal Disorder: 1 person, 4.76%
Migraine (headache): 1 person, 4.76%
Hypersensitivity: 1 person, 4.76%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Sutent and have Subdural haematoma?

- Check whether Subdural haematoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sutent:

Sutent (44,554 reports)

Browse all side effects of Sutent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Subdural haematoma:

Subdural haematoma (998 drugs)

Browse all the conditions that are associated with Subdural haematoma:

Subdural haematoma (1,084 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sunitinib malate (the active ingredients of Sutent) and Sutent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.